Enanta Pharmaceuticals Inc (ENTA)

[vinmantoo]

if ENTA continues to burn cash and the assigned value is based on the cash, it only makes sense to me that as the on hand cash goes lower, the stock price does as well.

That is true for just about every biotech. However, you talked about a $1.50 to $3 stock price without any timeline. ENTA said they have enough cash to fund operations into 2027 so that prediction will hold if nothing positive develops in the pipeline by then and no partnership is struck for EDP-235. I can't say that is impossible but it isn't imminent.